Cholesteryl ester transfer protein inhibition: Effect on reverse cholesterol transport?

Cholesteryl ester transfer protein inhibition: Effect on reverse cholesterol transport?

Rensen, P.C.N.
Havekes, L.M.
TNO Kwaliteit van Leven

2006

Chemicals / CAS: 2 methylpropanethioic acid s [2 [1 (2 ethylbutyl)cyclohexylcarboxamido]phenyl] ester, 211513-37-0; atorvastatin, 134523-00-5, 134523-03-8; nicotinic acid, 54-86-4, 59-67-6; torcetrapib, 262352-17-0; Carrier Proteins; CETP protein, human; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Cholesterol, HDL; Glycoproteins; Lipoproteins, HDL

Biology
Biomedical Research
2 methylpropanethioic acid s [2 [1 (2 ethylbutyl)cyclohexylcarboxamido]phenyl] ester
Atorvastatin
Cholesterol ester transfer protein inhibitor
Fibric acid derivative
High density lipoprotein cholesterol
Hydroxymethylglutaryl coenzyme A reductase inhibitor
Nicotinic acid
Torcetrapib
Atherosclerosis
Cholesterol transport
Clinical trial
Drug efficacy
Drug mechanism
Dyslipidemia
Editorial
Ischemic heart disease
Nonhuman
Plasma clearance
Protein expression
Reverse cholesterol transport
Animals
Biological Transport
Cardiovascular Diseases
Carrier Proteins
Cholesterol Ester Transfer Proteins
Cholesterol Esters
Cholesterol, HDL
Glycoproteins
Humans
Lipid Metabolism
Lipoproteins, HDL
Rabbits
Risk Factors

http://resolver.tudelft.nl/uuid:e45b3de9-d170-4999-90d1-f6c0bb2b43af

https://doi.org/10.1161/01.atv.0000214979.24518.95

239189

1079-5642

Arteriosclerosis, Thrombosis, and Vascular Biology, 26 (4), 681-684

article